Biotechnology - Nektar Therapeutics

Filter

Current filters:

Nektar Therapeutics

Popular Filters

Nektar’s etirinotecan pegol passes Ph III interim efficacy analysis

14-01-2014

US biotech firm Nektar Therapeutics says that the Independent Data Monitoring Committee created to provide…

BiotechnologyNektar TherapeuticsOncologyResearch

Back to top